Infectious Disease Campaigns

Upping the Anti - Staying ahead of infectious disease threats

Infectious diseases do not stand still. Bacteria adapt, viruses emerge and fungal threats continue to grow. Staying ahead of these evolving challenges demands sustained innovation, investment and collaboration.

 

Yet the future of anti-infective innovation is far from guaranteed. With specialist expertise, capabilities and investment under pressure, we must act now to ensure we have the tools and treatments needed to respond to tomorrow's threats.

 

For more than 110 years, we have remained committed to advancing anti-infectives. Now, we are Upping the Anti; we're reinforcing our commitment: continuing to innovate, invest and collaborate across antibiotics, antivirals and antifungals to help build a more resilient future.

Why infectious disease innovation cannot wait

Discover why sustaining the science, investment and partnerships behind anti-infective innovation is critical to staying ahead of future health threats

 

Our latest report explores the challenges facing the anti-infective innovation ecosystem, why protecting specialist capabilities matters, and the collective action needed to ensure innovation continues.

 

Download “Why infectious disease innovation cannot wait” here 

Antimicrobial resistance: the value of antibiotics

What would healthcare look like if antibiotics were no longer effective?

Antibiotics are the foundations of modern medicine – supporting everything from surgery and cancer treatment to safe childbirth. But antimicrobial resistance (AMR) is on the rise, threatening to strip away a century of medical progress.

AMR could cause close to 2 million deaths per year globally by 2050 if we don’t take action now.*

At Shionogi we are committed to working with partners across borders and sectors to support innovation, strengthen stewardship, and protect sustainable access to effective antibiotics.

We need to act now to protect our present and secure our future.

*Global burden of bacterial antimicrobial resistance 1990–2021: a systematic analysis with forecasts to 2050. The Lancet

The next generation explore the issue of superbugs

AMR poses a huge threat to the health of the next generation, so we asked young people from across the continent for their thoughts on the crisis.

This special film was made for World AMR Awareness Week 2024, and we are very grateful to all the participants.

Defending Our Health: Unravelling Antimicrobial Resistance

Sustainable antibiotic development and international collaboration are essential in the fight against antimicrobial resistance. Ongoing innovation and policy change are also key to ensure pharmaceutical investment in new antimicrobials can continue.

We developed and funded a short film, which explores the need for collective action against AMR as part of the news-style programme, ‘Defending Our Health: Unravelling Antimicrobial Resistance’, in partnership with ITN Business.1,2 Watch our film here:

AMR in focus

Read our special 'In Focus' publication to find out more about the global challenge of AMR and how we are working to help tackle this important issue.

 

At Shionogi, we remain committed to delivering scientific innovation and advocating for policy change. We are playing our part to help advance the science, so that world leaders and clinicians can deliver the best defence against AMR.

NP-EU-NP-0395 Nov 2026